Proto Script Pharmaceutical PSCR Stock
Proto Script Pharmaceutical Price Chart
Proto Script Pharmaceutical PSCR Financial and Trading Overview
Proto Script Pharmaceutical stock price | 0.0003 USD |
Previous Close | 0.0002 USD |
Open | 0.0002 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.0002 - 0.0002 USD |
52 Week Range | 0.0002 - 0.0011 USD |
Volume | 7.85K USD |
Avg. Volume | 1.79K USD |
Market Cap | 90.42K USD |
Beta (5Y Monthly) | -1.404577 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
PSCR Valuation Measures
Enterprise Value | 384.07K USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.14945526 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.635 |
Enterprise Value/EBITDA | -0.399 |
Trading Information
Proto Script Pharmaceutical Stock Price History
Beta (5Y Monthly) | -1.404577 |
52-Week Change | 0% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.0011 USD |
52 Week Low | 0.0002 USD |
50-Day Moving Average | 0.0002 USD |
200-Day Moving Average | 0.00049 USD |
PSCR Share Statistics
Avg. Volume (3 month) | 1.79K USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 49.14M |
Float | 44.82M |
Short Ratio | N/A |
% Held by Insiders | 10.17% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2016 |
Most Recent Quarter (mrq) | September 30, 2017 |
Next Fiscal Year End | December 31, 2017 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -160.49% |
Gross Margin | 58.15% |
EBITDA Margin | -159.10% |
Management Effectiveness
Return on Assets (ttm) | -240.96% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 604.98K USD |
Revenue Per Share (ttm) | 0.004 USD |
Quarterly Revenue Growth (yoy) | 17.80% |
Gross Profit (ttm) | 564.47K USD |
EBITDA | -962569 USD |
Net Income Avi to Common (ttm) | -8386297 USD |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | N/A |
Total Cash Per Share (mrq) | N/A |
Total Debt (mrq) | 372.75K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.111 |
Book Value Per Share (mrq) | -0.029 |
Cash Flow Statement
Operating Cash Flow (ttm) | -303097 USD |
Levered Free Cash Flow (ttm) | 406.84K USD |
Profile of Proto Script Pharmaceutical
Country | United States |
State | CA |
City | Rancho Cucamonga |
Address | 9830 6th Street |
ZIP | 91730 |
Phone | 855-476-7679 |
Website | https://www.psphomecare.com |
Industry | Specialty Business Services |
Sector(s) | Industrials |
Full Time Employees | N/A |
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. The company serves federal, state, and private insurance providers. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California.
Q&A For Proto Script Pharmaceutical Stock
What is a current PSCR stock price?
Proto Script Pharmaceutical PSCR stock price today per share is 0.0003 USD.
How to purchase Proto Script Pharmaceutical stock?
You can buy PSCR shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Proto Script Pharmaceutical?
The stock symbol or ticker of Proto Script Pharmaceutical is PSCR.
Which industry does the Proto Script Pharmaceutical company belong to?
The Proto Script Pharmaceutical industry is Specialty Business Services.
How many shares does Proto Script Pharmaceutical have in circulation?
The max supply of Proto Script Pharmaceutical shares is 301.39M.
What is Proto Script Pharmaceutical Price to Earnings Ratio (PE Ratio)?
Proto Script Pharmaceutical PE Ratio is now.
What was Proto Script Pharmaceutical earnings per share over the trailing 12 months (TTM)?
Proto Script Pharmaceutical EPS is 0 USD over the trailing 12 months.
Which sector does the Proto Script Pharmaceutical company belong to?
The Proto Script Pharmaceutical sector is Industrials.